CID-103 / CASI, Alesta Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CID-103 / CASI, Precision Autoimmune Therap
NCT04758767: CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma

Active, not recruiting
1
10
Europe
CID-103
CASI Pharmaceuticals, Inc.
Multiple Myeloma
09/23
09/24

Download Options